2Goodwin CS. Duodenal ulcer,campylobacter pylori, and the "leaking roof" concept [J]. Lancet,1988,2(8 626):1 467-1 469.
3Levis S, Beardshall K, Haddad G, et al. Campylobcter pylori and duodenal ulcer: the gastrin link [J]. Lancet, 1989,1(8 648):1 167-1 168.
4Wyatt JI, Rathbone BJ, Sobala GM.Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation [J]. J Clin Pathol, 1990,43 (12):981-986.
5Parsonnet J. Helicobacter pylori and gastric cancer [J]. Gastroenterol Clin North Am, 1993,22(1):89-104.
6EI-Omar E, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer [J]. Nature, 2000, 404(6 776): 398-402.
7Malfertheinerl P, Megraud F, O′Morain C, et al. The European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection. The Masstricht 2-2000 Consensus Report [J]. Aliment Pharmacol Ther,2002,16 (2):167-180.
8Wang WH, Wong BCY, Mukhopadhyay AK, et al. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong [J]. Aliment Pharmacol Ther, 2000,14(7):901-910.
9Megraud F. Basis for the management of drug-resistant Helicobacter pylori infection [J]. Drugs,2004,64(17): 1 893-1 904.
10Gerrits MM, Van der Wouden EJ, Bax DA, et al. Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori [J]. J Med Microbiol,2004,53(Pt 11):1 123-1 128.
二级参考文献2
1Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R,Axon A, Graham DY, Tytgat G. European Helicobacter pylori Study Group (EHpSG). Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-180.
